We have the pleasure to announce that Pharmya has received CIR accreditation for a three-year period (2020, 2021 and 2022) from the French Ministry of Higher Education and Research.

The French R&D tax credit initiative (‘Crédit d’Impôt Recherche’, CIR) gives eligible research-based French companies, who are subject to corporate tax in France, the ability to claim tax relief on costs generated in R&D activities outsourced to Pharmya.